BioCentury
ARTICLE | Company News

Pear, Sandoz launch first FDA-approved digital therapeutic

November 20, 2018 8:57 PM UTC

Pear Therapeutics Inc. (Boston, Mass.) and Sandoz launched reSET, the first FDA-authorized prescription digital therapeutic, in the U.S. FDA approved reSET in September 2017 to treat substance use disorder in conjunction with outpatient clinician-delivered care.

The therapy comprises interactive treatment modules that deliver cognitive behavioral therapy, and a clinician dashboard that tracks patient-reported substance use, cravings and triggers...